XORTX Therapeutics Inc. (XRTX) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
XRTX Revenue Growth
XRTX Revenue Analysis (2014–2025)
As of May 8, 2026, XORTX Therapeutics Inc. (XRTX) generated trailing twelve-month (TTM) revenue of $0. The most recent quarter (Q4 2025) recorded $0 in revenue.
Looking at the longer-term picture, XRTX's historical revenue data shows various trends over time.
When compared to Healthcare sector peers including ARDX (+18.2% YoY), CPRX (+19.8% YoY), and KRYS (+25.1% YoY). Compare XRTX vs ARDX →
XRTX Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| XRTXCurrent | $0 | - | - | - | |
 ARDX | $407M | +18.2% | +121.9% | -10.1% | |
 CPRX | $589M | +19.8% | +37.7% | 43.8% | |
 KRYS | $389M | +25.1% | - | 41.5% | |
 FOLD | $634M | +20.0% | +19.4% | 5.4% | |
 RARE | $673M | +13.3% | +19.9% | -79.5% |
XRTX Historical Revenue Data (2014–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $0 | - | $-156,657 | - | $-4,549,591 | - |
| 2024 | $0 | - | $-160,660 | - | $-5,641,938 | - |
| 2023 | $0 | - | $-141,959 | - | $-4,805,077 | - |
| 2022 | $0 | - | $-75,268 | - | $-12,433,624 | - |
| 2021 | $0 | - | $-17,882 | - | $-2,902,878 | - |
| 2020 | $0 | - | $-20,439 | - | $-1,082,239 | - |
| 2019 | $0 | - | $-19,900 | - | $-565,965 | - |
| 2018 | $0 | - | $-19,316 | - | $-1,069,346 | - |
| 2017 | $0 | - | $0 | - | $-427,107 | - |
| 2016 | $0 | - | $0 | - | $-389,315 | - |
See XRTX's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs XRTX Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare XRTX vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonXRTX — Frequently Asked Questions
Quick answers to the most common questions about buying XRTX stock.
Is XRTX's revenue growth accelerating or slowing?
XRTX TTM revenue: $0.00. YoY growth: N/A. 5-year CAGR: N/A.
What is XRTX's long-term revenue growth rate?
XORTX Therapeutics Inc.'s 5-year revenue CAGR of N/A reflects the variable expansion pattern. Current YoY growth of N/A is near this long-term average.
How is XRTX's revenue distributed by segment?
XRTX reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.